RPID (Rapid Micro Biosystems) Total Liabilities : $21.47 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Rapid Micro Biosystems Total Liabilities?

Rapid Micro Biosystems's Total Liabilities for the quarter that ended in Sep. 2024 was $21.47 Mil.

Rapid Micro Biosystems's quarterly Total Liabilities increased from Mar. 2024 ($21.79 Mil) to Jun. 2024 ($22.50 Mil) but then declined from Jun. 2024 ($22.50 Mil) to Sep. 2024 ($21.47 Mil).

Rapid Micro Biosystems's annual Total Liabilities increased from Dec. 2021 ($20.19 Mil) to Dec. 2022 ($26.48 Mil) but then declined from Dec. 2022 ($26.48 Mil) to Dec. 2023 ($25.46 Mil).

Rapid Micro Biosystems Total Liabilities Historical Data

The historical data trend for Rapid Micro Biosystems's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Micro Biosystems Total Liabilities Chart

Rapid Micro Biosystems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

32.41

45.18

20.19

26.48

25.46

Rapid Micro Biosystems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															22.38	25.46	21.79	22.50	21.47

Rapid Micro Biosystems Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Rapid Micro Biosystems's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.986	+	(6.214	+	0.263
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	25.46

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	143.452	-	117.989
	=	25.46

Rapid Micro Biosystems's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.92	+	(5.261	+	0.289
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	21.47

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	105.843	-	84.373
	=	21.47

Rapid Micro Biosystems Total Liabilities Related Terms

Thank you for viewing the detailed overview of Rapid Micro Biosystems's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Micro Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rapid Micro Biosystems Inc (NAS:RPID) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Pawtucket Boulevard West, Suite 280, Lowell, MA, USA, 01854

Website

https://www.rapidmicrobio.com

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Executives

Melinda Litherland Pei	director	1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Kirk Malloy	director	5200 ILLUMINA WAY, SAN DIEGO CA 92122
Sean M Wirtjes	officer: Chief Financial Officer	C/O VARIAN, INC., 3120 HANSEN WAY, M/S D-083, PALO ALTO CA 94304-1030
Spignesi Robert G. Jr.	director, officer: President and CEO	C/O RAPID MICRO BIOSYSTEMS, INC., 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854
Richard S Kollender	director	C/O QUAKER BIOVENTURES, CIRA CENTRE, 2929 ARCH STREET, 3RD FLOOR, PHILADELPHIA PA 19104-2868
Kennedy Lewis Capital Partners Master Fund Ii Lp	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Darren Richman	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Klm Gp Llc	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Investment Management Llc	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Management Lp	10 percent owner	225 LIBERTY STREET, SUITE 4210, NEW YORK NY 10281
David Chene	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Capital Partners Master Fund Iii Lp	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Gp Iii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Investment Holdings Ii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Gp Ii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120